2.Misplaced: A case of cesarean scar pregnancy.
Hannah Yzabelle Liao CHUA ; Marivic C. AGULTO-MERCADAL ; Judy Ong FUENTES
Philippine Journal of Obstetrics and Gynecology 2025;49(3):180-186
A 40-year-old, gravida 3 para 2 (1-1-0-2), previous primary cesarean section for nonreassuring fetal status, presented at a tertiary hospital for confirmation of cesarean scar pregnancy (CSP). Transvaginal ultrasound confirmed a CSP at 8 2/7 weeks age of gestation with good embryonic cardiac activity, raising concern for early placenta accreta spectrum. A multidisciplinary team composed of an obstetrician, advanced pelvic surgeon, urologist, and anesthesiologist managed the patient. The patient underwent total abdominal hysterectomy with bilateral salpingectomy, as the patient has a completed family size. Before the procedure, she was given cefuroxime as prophylactic antibiotic. Intraoperatively, there were dense adhesions between the posterior bladder wall and the previous cesarean section scar. Inadvertent injury to the bladder wall was incurred during adhesiolysis. Cystorrhaphy was done by a urologist, while the rest of the surgery was unremarkable, with a 450 ml estimated blood loss. The postoperative course was unremarkable. Bladder rest was achieved by maintaining an indwelling Foley catheter, which remained in place upon discharge on postoperative day 3 and was continued for 7 days thereafter. At follow-up, a successful voiding trial was conducted, confirming the return of normal bladder function.
Human ; Female ; Adult: 25-44 Yrs Old ; Cesarean Section ; Salpingectomy ; Hysterectomy ; Fetal Distress ; Placenta Accreta ; Cefuroxime ; Catheters ; Cicatrix
3.Minimally invasive therapeutic modalities for pediatric urolithiasis: A single center experience from the Philippines
Kyousuke A. Kamiya ; Carlos Ramon N. Torres Jr.
Philippine Journal of Urology 2024;34(1):1-8
		                        		
		                        			Introduction:
		                        			There is a limited data on the incidence of  pediatric urolithiasis in the Philippines as well as studies on how it is managed. With the advent of  endourology, there is already an evident shift from open stone surgery to minimally invasive surgery as first line in the treatment of  pediatric urolithiasis. A tertiary referral center in the country caters to most pediatric urolithiasis cases in the country and offers the different minimally invasive modalities outlined in the latest guidelines. This study aimed to review the different minimally invasive therapeutic modalities for pediatric urolithiasis and its outcomes in the past ten years in a tertiary referral center in the Philippines.
		                        		
		                        			Methods:
		                        			This retrospective study was conducted through charts review of  all pediatric patients (0-18 years) who underwent stone surgery from January 2012 to December 2022.  Demographic and clinical data, stone characteristics, types of  stone surgery, and outcomes were obtained.
		                        		
		                        			Results:
		                        			A total of  87 pediatric patients (54 boys, 33 girls) with 105 urolithiases were analyzed. The patients had a mean age of  13 years, with an interquartile range (IQR) spanning from 6 to 18 years. Among them, 62.07% were male, while 37.93% were female. The most prevalent symptom reported was flank pain, affecting 41.38% of  the patients, followed by urinary tract infections (UTI) (11.49%) and gross hematuria (8.05%). For the management, 82.86% of  the patients underwent minimally invasive stone procedures with extracorporeal shockwave lithotripsy (ESWL) as the most common  procedure  (44.76%)  and  ureterolithiases  as  the  most  common  stone  (43.81%).  On  the  other hand, 17.14% of  the subjects underwent open stone surgery done mostly on cystolithiases and large ureterolithiases (38.89% each).  All patients recovered and were discharged post operatively.
		                        		
		                        			Conclusion
		                        			The institution practices minimally invasive approaches in the majority of  pediatric patients with urolithiasis. Open stone surgery is reserved for patient with large complex stones and those with anatomic abnormalities.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			 Lithotripsy
		                        			;
		                        		
		                        			 Ureteroscopy
		                        			
		                        		
		                        	
4.Repair of perineal urethrostomy stenosis using buccal mucosal graft in a patient diagnosed with body dysmorphia and who previously underwent total penectomy, bilateral orchiectomy, and scrotectomy: A case report
Patricia Anne Tagle ; Raul Carlo C. Andutan ; Mark Joseph J. Abalajon
Philippine Journal of Urology 2024;34(2):86-92
Body dysmorphia is a debilitating disorder that centralizes on a preoccupation with one’s physical appearance. Often, these individuals seek surgical correction in an effort to subdue this preoccupation. A majority of complications from feminizing gender reassignment surgery, consists of urethral stricture or stenosis, leading to voiding dysfunction. The patient is 39-year old male who underwent bilateral nipple removal, bilateral orchiectomy, scrotectomy and total penectomy with perineal urethrostomy, one year prior to consult. The patient eventually presented with acute urinary retention secondary to perineal urethrostomy stenosis. Urethroplasty with revision of perineal urethrostomy site using a buccal graft was done; and on follow up, he was noted to have good urine flow on uroflowmetry with mild lower urinary tract symptoms. Complex urethral strictures may be noted in patients with prior reconstructive history and lengthy areas of fibrosis. Although perineal urethrostomy is a valid surgical course of treatment for patients with complex strictures, improper technique, suboptimal patient factors, and, poor healing may lead to stenosis. The study aims to describe the use of a buccal graft as a viable alternative and easily reproducible technique to augment a revision perineal urethrostomy and lessen the recurrence of stenosis.
Human ; Male ; Adult: 25-44 Yrs Old ; Gender Reassignment Surgery ; Sex Reassignment Surgery
5.Prostate synovial sarcoma in a 29-year-old male: A case report
Ronald Andrew C. Mijares ; Marlo Vir C. Batucan
Philippine Journal of Urology 2024;34(2):102-105
Synovial sarcoma is an extremely rare soft tissue cancer that predominantly affects young adults, typically occurring at the para-articular region of the extremities. Primary synovial sarcoma of the prostate is exceptionally uncommon in clinical practice.
Presented here is a case of a 29-year-old male with prostatic synovial sarcoma. He experienced lower urinary tract symptoms and eventually had urine retention. Also discussed here are the imaging findings, treatment plan, and differential diagnosis.
The patient experienced urinary frequency, dysuria, and acute urinary retention, which led to the insertion of a Foley catheter. Subsequent ultrasound scans revealed a large lobulated solid prostate gland. A prostate biopsy confirmed the presence of a malignant spindle cell neoplasm, indicating a prostatic stromal sarcoma. Immunohistomorphologic findings (TLE-1+, STAT6-, S100-, CD34-, ER-, PR-) were consistent with a diagnosis of Monophasic Synovial Sarcoma. The patient underwent six cycles of neoadjuvant chemotherapy before a Radical Prostatectomy was performed. The postoperative course was uneventful, and the patient was discharged in a significantly improved condition.
Given the rarity of this condition, the authors are reporting a case of prostatic synovial sarcoma and how they managed it. They performed a radical prostatectomy with neoadjuvant chemotherapy, which had a positive effect. Subsequent postoperative monitoring and imaging showed no further symptoms.
Human ; Male ; Adult: 25-44 Yrs Old ; Prostate Cancer ; Prostatic Neoplasms ; Prostatectomy
6.Research Progress in Preoperative Evaluation of Lymph Node Metastasis of Bladder Cancer.
Li-Juan WANG ; Zi-Xiao LIU ; Wei HU ; Yang LIU ; Wei-Jun QIN ; Xiao-Pan XU ; Hong-Bing LU
Acta Academiae Medicinae Sinicae 2023;45(3):464-470
		                        		
		                        			
		                        			Bladder cancer is a common malignant tumor of the urinary system.The prognosis of patients with positive lymph nodes is worse than that of patients with negative lymph nodes.An accurate assessment of preoperative lymph node statushelps to make treatmentdecisions,such as the extent of pelvic lymphadenectomy and the use of neoadjuvant chemotherapy.Imaging examination and pathological examination are the primary methods used to assess the lymph node status of bladder cancer patients before surgery.However,these methods have low sensitivity and may lead to inaccuate staging of patients.We reviewed the research progress and made an outlook on the application of clinical diagnosis,imaging techniques,radiomics,and genomics in the preoperative evaluation of lymph node metastasis in bladder cancer patients at different stages.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymphatic Metastasis
		                        			;
		                        		
		                        			Neoplasm Staging
		                        			;
		                        		
		                        			Cystectomy/methods*
		                        			;
		                        		
		                        			Urinary Bladder Neoplasms/pathology*
		                        			;
		                        		
		                        			Lymph Node Excision/methods*
		                        			;
		                        		
		                        			Lymph Nodes/pathology*
		                        			
		                        		
		                        	
7.FOXA1 in prostate cancer.
Hui-Yu DONG ; Lei DING ; Tian-Ren ZHOU ; Tao YAN ; Jie LI ; Chao LIANG
Asian Journal of Andrology 2023;25(3):287-295
		                        		
		                        			
		                        			Most prostate cancers initially respond to androgen deprivation therapy (ADT). With the long-term application of ADT, localized prostate cancer will progress to castration-resistant prostate cancer (CRPC), metastatic CRPC (mCRPC), and neuroendocrine prostate cancer (NEPC), and the transcriptional network shifted. Forkhead box protein A1 (FOXA1) may play a key role in this process through multiple mechanisms. To better understand the role of FOXA1 in prostate cancer, we review the interplay among FOXA1-targeted genes, modulators of FOXA1, and FOXA1 with a particular emphasis on androgen receptor (AR) function. Furthermore, we discuss the distinct role of FOXA1 mutations in prostate cancer and clinical significance of FOXA1. We summarize possible regulation pathways of FOXA1 in different stages of prostate cancer. We focus on links between FOXA1 and AR, which may play different roles in various types of prostate cancer. Finally, we discuss FOXA1 mutation and its clinical significance in prostate cancer. FOXA1 regulates the development of prostate cancer through various pathways, and it could be a biomarker for mCRPC and NEPC. Future efforts need to focus on mechanisms underlying mutation of FOXA1 in advanced prostate cancer. We believe that FOXA1 would be a prognostic marker and therapeutic target in prostate cancer.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Androgen Antagonists/therapeutic use*
		                        			;
		                        		
		                        			Androgens/metabolism*
		                        			;
		                        		
		                        			Hepatocyte Nuclear Factor 3-alpha/metabolism*
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Prostatic Neoplasms, Castration-Resistant/drug therapy*
		                        			;
		                        		
		                        			Receptors, Androgen/metabolism*
		                        			
		                        		
		                        	
8.Serum estradiol levels decrease after oophorectomy in transmasculine individuals on testosterone therapy.
Sahil KUMAR ; Elise BERTIN ; Cormac O'DWYER ; Amir KHORRAMI ; Richard WASSERSUG ; Smita MUKHERJEE ; Neeraj MEHRA ; Marshall DAHL ; Krista GENOWAY ; Alexander G KAVANAGH
Asian Journal of Andrology 2023;25(3):309-313
		                        		
		                        			
		                        			Transmasculine individuals, considering whether to undergo total hysterectomy with bilateral salpingectomy, have the option to have a concomitant oophorectomy. While studies have evaluated hormone changes following testosterone therapy initiation, most of those patients have not undergone oophorectomy. Data are currently limited to support health outcomes regarding the decision to retain or remove the ovaries. We performed a retrospective chart review of transmasculine patients maintained on high-dose testosterone therapy at a single endocrine clinic in Vancouver, British Columbia, Canada. Twelve transmasculine individuals who underwent bilateral oophorectomy and had presurgical and postsurgical serum data were included. We identified 12 transmasculine subjects as controls, who were on testosterone therapy and did not undergo oophorectomy, but additionally matched to the first group by age, testosterone dosing regimen, and body mass index. There was a statistically significant decrease in the estradiol levels of case subjects postoophorectomy, when compared to presurgical estradiol levels (P = 0.02). There was no significant difference between baseline estradiol levels between control and case subjects; however, the difference in estradiol levels at follow-up measurements was significant (P = 0.03). Total testosterone levels did not differ between control and case subjects at baseline and follow-up (both P > 0.05). Our results demonstrate that oophorectomy further attenuates estradiol levels below what is achieved by high-dose exogenous testosterone alone. Correlated clinical outcomes, such as impacts on bone health, were not available. The clinical implications of oophorectomy versus ovarian retention on endocrinological and overall health outcomes are currently limited.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Testosterone/therapeutic use*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Ovariectomy
		                        			;
		                        		
		                        			Hysterectomy/methods*
		                        			;
		                        		
		                        			Estradiol
		                        			
		                        		
		                        	
9.Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China.
Xiao-Hao RUAN ; Tsun Tsun STACIA CHUN ; Da HUANG ; Hoi-Lung WONG ; Brian Sze-Ho HO ; Chiu-Fung TSANG ; Terence Chun-Ting LAI ; Ada Tsui-Lin NG ; Rong NA ; James Hok-Leung TSU
Asian Journal of Andrology 2023;25(3):345-349
		                        		
		                        			
		                        			The long-term survival outcomes of radical prostatectomy (RP) in Chinese prostate cancer (PCa) patients are poorly understood. We conducted a single-center, retrospective analysis of patients undergoing RP to study the prognostic value of pathological and surgical information. From April 1998 to February 2022, 782 patients undergoing RP at Queen Mary Hospital of The University of Hong Kong (Hong Kong, China) were included in our study. Multivariable Cox regression analysis and Kaplan-Meier analysis with stratification were performed. The 5-year, 10-year, and 15-year overall survival (OS) rates were 96.6%, 86.8%, and 70.6%, respectively, while the 5-year, 10-year, and 15-year PCa-specific survival (PSS) rates were 99.7%, 98.6%, and 97.8%, respectively. Surgical International Society of Urological Pathology PCa grades (ISUP Grade Group) ≥4 was significantly associated with poorer PSS (hazard ratio [HR] = 8.52, 95% confidence interval [CI]: 1.42-51.25, P = 0.02). Pathological T3 stage was not significantly associated with PSS or OS in our cohort. Lymph node invasion and extracapsular extension might be associated with worse PSS (HR = 20.30, 95% CI: 1.22-336.38, P = 0.04; and HR = 7.29, 95% CI: 1.22-43.64, P = 0.03, respectively). Different surgical approaches (open, laparoscopic, or robotic-assisted) had similar outcomes in terms of PSS and OS. In conclusion, we report the longest timespan follow-up of Chinese PCa patients after RP with different approaches.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Prostatic Neoplasms/pathology*
		                        			;
		                        		
		                        			Prostate/pathology*
		                        			;
		                        		
		                        			Prostatectomy
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Neoplasm Grading
		                        			
		                        		
		                        	
10.Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia.
Jing ZHOU ; Zhu-Feng PENG ; Pan SONG ; Lu-Chen YANG ; Zheng-Huan LIU ; Shuai-Ke SHI ; Lin-Chun WANG ; Jun-Hao CHEN ; Liang-Ren LIU ; Qiang DONG
Asian Journal of Andrology 2023;25(3):356-360
		                        		
		                        			
		                        			Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0-2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding (P = 0.79), urinary retention (P = 0.40), fever (P = 0.55), and readmission (P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Prostatic Hyperplasia/complications*
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Transurethral Resection of Prostate/adverse effects*
		                        			;
		                        		
		                        			Treatment Outcome
		                        			;
		                        		
		                        			Enhanced Recovery After Surgery
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail